COVID And Aduhelm On The Agenda At Denver Alzheimer's Meeting
Short Wave
00:00
Intro
This chapter explores insights from the annual Alzheimer's Association International Conference, addressing the effects of COVID-19 on Alzheimer's research. It highlights potential connections between the two and discusses a new FDA-approved drug for Alzheimer's treatment.
Play episode from 00:00
Transcript
